These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
166 related items for PubMed ID: 15006313
41. Pharmacokinetics of norelgestromin and ethinyl estradiol from two consecutive contraceptive patches. Abrams LS, Skee DM, Wong FA, Anderson NJ, Leese PT. J Clin Pharmacol; 2001 Nov; 41(11):1232-7. PubMed ID: 11697756 [Abstract] [Full Text] [Related]
42. A comparison of bleeding patterns and cycle control using two transdermal contraceptive systems: a multicenter, open-label, randomized study. Gruber D, Skřivánek A, Serrani M, Lanius V, Merz M. Contraception; 2015 Feb; 91(2):105-12. PubMed ID: 25453582 [Abstract] [Full Text] [Related]
43. Comparative profiles of reliability, cycle control and side effects of two oral contraceptive formulations containing 150 micrograms desogestrel and either 30 micrograms or 20 micrograms ethinyl oestradiol. Akerlund M, Røde A, Westergaard J. Br J Obstet Gynaecol; 1993 Sep; 100(9):832-8. PubMed ID: 8218004 [Abstract] [Full Text] [Related]
44. Effect of a low-dose contraceptive patch on efficacy, bleeding pattern, and safety: a 1-year, multicenter, open-label, uncontrolled study. Wiegratz I, Bassol S, Weisberg E, Mellinger U, Merz M. Reprod Sci; 2014 Dec; 21(12):1518-25. PubMed ID: 24784719 [Abstract] [Full Text] [Related]
49. Clinical comparison of two low-dose oral contraceptives, Minulet and Mercilon, in women over 30 years of age. Kirkman RJ, Pedersen JH, Fioretti P, Roberts HE. Contraception; 1994 Jan; 49(1):33-46. PubMed ID: 8137624 [Abstract] [Full Text] [Related]
50. Adolescents' experiences using the contraceptive patch versus pills. Sucato GS, Land SR, Murray PJ, Cecchini R, Gold MA. J Pediatr Adolesc Gynecol; 2011 Aug; 24(4):197-203. PubMed ID: 21454110 [Abstract] [Full Text] [Related]
51. A review of transdermal hormonal contraception : focus on the ethinylestradiol/norelgestromin contraceptive patch. Graziottin A. Treat Endocrinol; 2006 Aug; 5(6):359-65. PubMed ID: 17107221 [Abstract] [Full Text] [Related]
53. Comparative contraceptive efficacy and mechanism of action of the norgestimate-containing triphasic oral contraceptive. London RS, Chapdelaine A, Upmalis D, Olson W, Smith J. Acta Obstet Gynecol Scand Suppl; 1992 Aug; 156():9-14. PubMed ID: 1324557 [Abstract] [Full Text] [Related]
54. Comparison of efficacy, cycle control, and tolerability of two low-dose oral contraceptives in a multicenter clinical study. Endrikat J, Düsterberg B, Ruebig A, Gerlinger C, Strowitzki T. Contraception; 1999 Nov; 60(5):269-74. PubMed ID: 10717778 [Abstract] [Full Text] [Related]
59. A multicenter, uncontrolled clinical investigation of the contraceptive efficacy, cycle control, and safety of a new low dose oral contraceptive containing 20 micrograms ethinyl estradiol and 100 micrograms levonorgestrel over six treatment cycles. Bannemerschult R, Hanker JP, Wünsch C, Fox P, Albring M, Brill K. Contraception; 1997 Nov; 56(5):285-90. PubMed ID: 9437556 [Abstract] [Full Text] [Related]
60. A clinical study of transdermal contraceptive patch in Thai women. Suwanmalee O, Taneepanichskul S. J Med Assoc Thai; 2006 Oct; 89 Suppl 4():S1-4. PubMed ID: 17726805 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]